Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rosemol George, Stephanie Hehlgans, Maximillian Fleischmann, Claus Rödel, Emmanouil Fokas & Franz Rödel. (2022) Advances in nanotechnology-based platforms for survivin-targeted drug discovery. Expert Opinion on Drug Discovery 17:7, pages 733-754.
Read now
Read now
Li Luo, Ting Du, Jiumeng Zhang, Wei Zhao, Hao Cheng, Yuping Yang, Yujiao Wu, Chunmei Wang, Ke Men & Maling Gou. (2016) Efficient inhibition of ovarian cancer by degradable nanoparticle-delivered survivin T34A gene. International Journal of Nanomedicine 11, pages 501-513.
Read now
Read now
Jagat R Kanwar, Rasika M Samarasinghe, Kuldeep Kumar, Ramesh Arya, Sanjeev Sharma, Shu-Feng Zhou, Sreenivasan Sasidharan & Rupinder K Kanwar. (2015) Cissus quadrangularis inhibits IL-1β induced inflammatory responses on chondrocytes and alleviates bone deterioration in osteotomized rats via p38 MAPK signaling. Drug Design, Development and Therapy 9, pages 2927-2940.
Read now
Read now
Articles from other publishers (7)
Anahita Marhounian Nezhad, Omid Farshad & Mohammad Hossein Morowvat. (2023) Evaluating the Cytotoxicity of Monolayered and Multilayered
Carbon Nanotubes on Three Different Human Cell Lines. Recent Patents on Biotechnology 17:2, pages 186-195.
Crossref
Crossref
Yangyong Mao, Mahpara Qamar, Sarmad Ahmad Qamar, Muhammad Imran Khan, Muhammad Bilal & Hafiz M.N. Iqbal. (2021) Insight of nanomedicine strategies for a targeted delivery of nanotherapeutic cues to cope with the resistant types of cancer stem cells. Journal of Drug Delivery Science and Technology 64, pages 102681.
Crossref
Crossref
Jake Mazur, Kislay Roy & Jagat R Kanwar. (2018) Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine 13:1, pages 105-137.
Crossref
Crossref
Jessica A. Gibbons, Jagat R. Kanwar & Rupinder K. Kanwar. (2015) Iron-free and iron-saturated bovine lactoferrin inhibit survivin expression and differentially modulate apoptosis in breast cancer. BMC Cancer 15:1.
Crossref
Crossref
Francesca Cavalieri, Giovanni L. Beretta, Jiwei Cui, Julia A. Braunger, Yan Yan, Joseph J. Richardson, Stella Tinelli, Marco Folini, Nadia Zaffaroni & Frank Caruso. (2015) Redox-Sensitive PEG–Polypeptide Nanoporous Particles for Survivin Silencing in Prostate Cancer Cells. Biomacromolecules 16:7, pages 2168-2178.
Crossref
Crossref
Yao-Kuang Wu, Chun-Yao Huang, Mei-Chen Yang, Chou-Chin Lan, Chih-Hsin Lee, Err-Cheng Chan & Kuei-Tien Chen. (2014) Nuclear survivin expression: a prognostic factor for the response to taxane–platinum chemotherapy in patients with advanced non-small cell lung cancer. Medical Oncology 31:8.
Crossref
Crossref
Ben Davidson, Yoav Smith, Jahn M. Nesland, Janne Kærn, Reuven Reich & Claes G. Tropè. (2013) Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion. Human Pathology 44:11, pages 2449-2460.
Crossref
Crossref